IDH2 and astrocytoma (excluding glioblastoma): Sublclonal IDH-mutant astrocytomas also have significantly better progression-free survival and OS compared to IDH-wild-type glioblastoma (Supplementary Figure 1), which suggests that they are not simply IDH-wild-type tumors with a late IDH1 mutation in a relatively small subclone.